Streetbeat News

Revenues

MOBX

Mobix Labs projects its Q3 2024 revenue to be in the range of $1.8M to $2.2M.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 9:33 pm

CURLF

Wedbush Securities upgraded Curaleaf Holdings, Inc. (OTC:CURLF) to Outperform, raising its 12-month price target to $7.00. Curaleaf, the largest U.S. cannabis company by market cap, reported Q1 2024 revenue of $338.9 million and projects $1.5 billion in revenue for 2025. The company is expanding domestically and internationally, with new product lines expected to contribute to long-term growth. Updated guidance anticipates consistent quarterly revenue growth, with a 2025 EBITDA forecast of $404 million.

Portfolio Pulse from Nicolás Jose Rodriguez

May 14, 2024 | 9:32 pm

MOBX

Mobix Labs reported a significant improvement in its Q2 2024 earnings with an EPS of $(0.21), up from $(0.94) year-over-year. Revenue also saw a substantial increase to $1.145M from just $32K in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 9:31 pm

AYRWF

CRLBF

CURLF

GTBIF

TCNNF

VRNOF

Smart and Safe Florida has launched a campaign with four ads advocating for the legalization of recreational marijuana in Florida, known as Amendment 3, set for a vote in November 2024. The campaign, supported by major cannabis companies including Trulieve, Verano Holdings, Curaleaf Holdings, AYR Wellness, Cresco Labs, Green Thumb Industries, and INSA, has spent over $5 million on ads. Trulieve alone has contributed over $40 million towards the initiative. The ads emphasize the benefits of a regulated market, including safety, revenue for schools, and freedom from outdated laws.

Portfolio Pulse from Maureen Meehan

May 14, 2024 | 9:21 pm

PXLW

Pixelworks anticipates Q2 total revenue of $8M-$9M, significantly below the estimated $16.5M, with an adjusted EPS loss of $(0.16)-$(0.13), worse than the estimated $(0.07). The company attributes the shortfall to near-term headwinds in its mobile business but expects a return to sequential growth in H2. The anticipated non-GAAP gross profit margin is between 50% and 52%.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 9:18 pm

CHCI

Comstock Holding Co (NASDAQ:CHCI) reported a 28.57% increase in Q1 EPS to $0.09 from $0.07 YoY and a 3.16% increase in sales to $10.60M from $10.28M YoY.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 9:14 pm

PBH

Prestige Consumer Healthcare projects its FY25 revenue growth to be around 1%, with an EPS range of $4.40-$4.46, which is below the estimated $4.62.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 9:02 pm

DFLI

Dragonfly Energy forecasts Q2 net sales of $14M-$15M with an estimated EPS loss of $(0.13) - $(0.16). The company anticipates growth in the RV market to benefit its OEM business in 2024.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 8:56 pm

EVOK

Evoke Pharma has reiterated its fiscal year 2024 net revenue forecast to be around $14 million, aligning closely with the analyst estimate of $14.081 million.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 8:55 pm

XPON

Expion360 reported a Q1 2024 EPS of $(0.31), a decrease from $(0.29) YoY. Revenue also fell to $971.859K from $1.507M YoY.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 8:52 pm